CTA-PB

E. I. du Pont de Nemours and Company (DuPont) - Q1 2005 10-Q Summary

Business Context and Reporting Period

This Form 10-Q covers the quarterly period ended March 31, 2005. DuPont is a diversified science and technology company. The reporting period reflects the completion of the separation of the Textiles & Interiors business (INVISTA) and the consolidation of DuPont Dow Elastomers LLC (DDE) as a Variable Interest Entity (VIE). The company operates globally with significant exposure to agricultural cycles, energy costs, and currency fluctuations.

Key Financial Metrics

Note: Q1 2004 debt figures are derived from the Q4 2004 balance sheet and the reported $2.5 billion increase in total debt during Q1 2005.

Material Changes vs. Prior Period

• Revenue: Net sales decreased 8% to $7.4 billion, primarily due to the absence of $1.5 billion in sales from the divested Textiles & Interiors business. Excluding portfolio changes, sales increased 9% driven by a 5% price increase, 2% currency benefit, and 2% volume growth.
• Profitability: Net income increased 45% to $967 million. This improvement is largely attributable to the absence of $161 million in litigation charges and $135 million in separation charges recorded in Q1 2004. Operating margins improved as Cost of Goods Sold (COGS) as a percent of sales dropped from 71% to 68%.
• Cash Flow: Operating cash flow was flat at $(6) million, a significant improvement over the $(282) million used in Q1 2004. This was due to strong earnings offset by seasonal working capital increases in Agriculture & Nutrition.
• Debt: Total debt increased by $2.5 billion to $8.9 billion, primarily driven by higher commercial paper balances to fund seasonal working capital needs.

Guidance, Outlook, and Risks

• Outlook: Management expects full-year capital spending (property, plant, and equipment) to be approximately $1.4 billion. The company is on track to generate 33% of 2005 revenue from new products introduced in the last five years.
• Dividends: The Board declared a Q2 2005 dividend of $0.37 per share, a 6% increase from the Q1 dividend.
• Share Repurchases: The company purchased 7.8 million shares for $405 million under its $2 billion buyback program.
• Legal & Environmental Risks:
  • Benlate: 91 cases remain pending regarding crop damage and personal injury. Costs incurred to date are approximately $1.9 billion, with $270 million recovered via insurance. A range of future losses cannot be estimated.
  • PFOA: A settlement regarding a class action in West Virginia was approved, establishing a reserve of $108 million in 2004. A $15 million reserve was added in Q1 2005 for EPA administrative complaints. Potential future medical monitoring costs are capped at $235 million if a link to disease is proven.
  • DDE Antitrust: DuPont bears disproportionate liability for DDE antitrust investigations. A $268 million reserve was established in 2004. DuPont will bear costs up to $150 million, with Dow contributing up to $72.5 million for costs exceeding that threshold.
• Unusual Items: The company expects to record pretax gains of approximately $40 million (Koch transfer) and $25 million (Textiles & Interiors asset sale) in Q2 2005. A $45 million gain is expected from the sale of DuPont Photomasks in Q2 2005.

Investor Verification Checklist

• Portfolio Adjustments: Verify the impact of the Textiles & Interiors divestiture and DDE consolidation on year-over-year comparisons.
• Seasonality: Confirm the impact of Q1 seasonality in the Agriculture & Nutrition segment on working capital and cash flow.
• Contingent Liabilities: Review the status of Benlate litigation and PFOA health studies, as potential losses exceed current accruals.
• Debt Structure: Analyze the increase in commercial paper usage to fund seasonal operations and its impact on net debt.
• Future Gains: Monitor the realization of expected Q2 2005 gains from asset sales and equity transfers.